Downregulation of phosphatase of regenerating liver-3 is involved in the inhibition of proliferation and apoptosis induced by emodin in the SGC-7901 human gastric carcinoma cell line

Experimental and Therapeutic Medicine

Volumn 3, Issue 6, 2012, Pages 1077-1081

  Sun, Zhen Hua ^a   Bu, Ping ^a  

^a CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

Author keywords

Apoptosis; Emodin; Gastric cancer; Phosphatase of regenerating liver 3; Proliferation

Indexed keywords

EMODIN; MESSENGER RNA; PHOSPHATASE; PHOSPHATASE OF REGENERATING LIVER 3 PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GENE CONTROL; GROWTH INHIBITION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; WESTERN BLOTTING;

EID: 84859471523     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.516     Document Type: Article

References (30)

1. Yamashita K, Sakuramoto S and Watanabe M: Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications. Surg Today 41: 24-38, 2011.
2. +pediatric ALL. Blood 101: 2743-2747, 2003.
3. Al-Aidaroos AQ and Zeng Q: PRL-3 phosphatase and cancer metastasis. J Cell Biochem 111: 1087-1098, 2010.
4. Guzinska-Ustymowicz K and Pryczynicz A: PRL-3, an emerging marker of carcinogenesis, is strongly associated with poor prognosis. Anticancer Agents Med Chem 11: 99-108, 2011.
5. Xu Y, Zhu M, Zhang S, Liu H, Li T and Qin C: Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma. Pathol Oncol Res 16: 169-175, 2010.
6. Dai N, Lu AP, Shou CC and Li JY: Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer. World J Gastroenterol 15: 1499-1505, 2009.
7. Bishop JD, Nien WL, Dauphinee SM and Too CK: Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells. J Endocrinol 190: 307-312, 2006.
8. Cai SR, Wang Z, Chen CQ, et al: Role of silencing phosphatase of regenerationg liver-3 expression by microRNA interference in the growth of gastric cancer. Chin Med J (Engl) 121: 2534-2538, 2008.
9. Wang H, Vardy LA, Tan CP, et al: PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase. Cancer Cell18: 52-62, 2010.
10. Wang Z, Cai SR, He YL, et al: High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients. Ann Surg Oncol 16: 208-219, 2009.
11. Olaku O and White JD: Herbal therapy use by cancer patients: a literature review on case reports. Eur J Cancer 47: 508-514, 2011.
12. Wang QJ, Cai XB, Liu MH, Hu H, Tan XJ and Jing XB: Apoptosis induced by emodin is associated with alterations of intracellular acidification and reactive oxygen species in EC-109 cells. Biochem Cell Biol 88: 767-774, 2010.
13. Meng G, Liu Y, Lou C and Yang H: Emodin suppresses lipopolysaccharide-induced pro-inflammatory responses and NF-kappaB activation by disrupting lipid rafts in CD14-negative endothelial cells. Br J Pharmacol 161: 1628-1644, 2010.
14. Gao Y, Liu H, Deng L, et al: Effect of emodin on neuropathic pain transmission mediated by P2X2/3 receptor of primary sensory neurons. Brain Res Bull 84: 406-413, 2011.
15. Xiong HR, Luo J, Hou W, Xiao H and Yang ZQ: The effect of emodin, an anthraquinone derivative extracted from the roots of Rheum tanguticum, against herpes simplex virus in vitro and invivo. J Ethnopharmacol 133: 718-723, 2011.
16. Ko JC, Su YJ, Lin ST, et al: Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2. Lung Cancer 69: 155-164, 2010.
17. Lai JM, Chang JT, Wen CL and Hsu SL: Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax mediated cytotoxicity in lung cancer cells. Eur J Pharmacol 623: 1-9, 2009.
18. Su YJ, Tsai MS, Kuo YH, et al: Role of Rad51 down-regulation and extracellular signal-regulated kinases 1 and 2 inactivation in emodin and mitomycin C-induced synergistic cytotoxicity in human non-small-cell lung cancer cells. Mol Pharmacol 77: 633-643, 2010.
19. Hsu CM, Hsu YA, Tsai Y, et al: Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells. Biochem Biophys Res Commun392: 473-478, 2010.
20. Li J, Liu P, Mao H, Wanga A and Zhang X: Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro. Oncol Rep 21: 1605-1610, 2009.
21. Lin SY, Lai WW, Ho CC, et al: Emodin induces apoptosis of human tongue squamous cancer SCC-4 cells through reactive oxygen species and mitochondria-dependent pathways. Anticancer Res 29: 327-335, 2009.
22. Wang W, Sun YP, Huang XZ, et al: Emodin enhances sensitivity of gallbladder cancer cells to platinum drugs via glutathion depletion and MRP1 downregulation. Biochem Pharmacol 79: 1134-1140, 2010.
23. Chun-Guang W, Jun-Qing Y, Bei-Zhong L, et al: Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo. Eur J Pharmacol 627: 33-41, 2010.
24. Huang Z, Chen G and Shi P: Effects of emodin on the gene expression profiling of human breast carcinoma cells. Cancer Detect Prev 32: 286-291, 2009.
25. Pascaru M, Tanase C, Vacaru AM, et al: Analysis of molecular determinants of PRL-3. J Cell Mol Med 13: 3141-3150, 2009.
26. Bessette DC, Qiu D and Pallen CJ: PRL PTPs: mediators and markers of cancer progression. Cancer Metastasis Rev 27: 231-252, 2008.
27. Hao RT, Zhang XH, Pan YF, et al: Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer. J Cancer Res Clin Oncol 136: 1349-1357, 2010.
28. Reich R, Hadar S and Davidson B: Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma. Int J Mol Sci 12: 1133-1145, 2011.
29. Ren T, Jiang B, Xing X, et al: Prognostic significance of phosphatase of regenerating liver-3 expression in ovarian cancer. Pathol Oncol Res 15: 555-560, 2009.
30. Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N and Watanabe M: Phosphatase of regenerating liver-3 as a prognostic biomarker in histologically node-negative gastric cancer. Oncol Rep 21: 1467-1475, 2009.